Results 121 to 130 of about 5,038 (137)

miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β

Cell Research, 2010
Shuang Yang, Shen Wenwen
exaly  

miR‐145, miR‐133a and miR‐133b: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

International Journal of Cancer, 2010
Hideki Enokida, Isamu Hoshino, Naohiko Seki   +2 more
exaly  

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer

British Journal of Cancer, 2011
Nijiro Nohata, Nakagawa M, Seki N
exaly  

Downregulation of miR‐122 in the rodent and human hepatocellular carcinomas

Journal of Cellular Biochemistry, 2006
Igor Pogribny, Tasneem Motiwala
exaly  

miR-195, miR-455-3p and miR-10a∗ are implicated in acquired temozolomide resistance in glioblastoma multiforme cells

Cancer Letters, 2010
Michiko Matsuse, Shunichi Yamashita, Norisato Mitsutake   +2 more
exaly  

Association between single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and prostate cancer risk in a sample of Iranian population

Journal of Advanced Research, 2016
Mohammad Hashemi, Mohsen Taheri, Mohammad Hashemi   +2 more
exaly  

Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer

International Journal of Cancer, 2011
Susan Clark, Lars Dyrskjøt, Michael Börre   +2 more
exaly  

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

British Journal of Cancer, 2010
Nakagawa M, Seki N, Enokida H
exaly  

MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3

Cancer Letters, 2013
Xuguang Zheng
exaly  

The functional significance of miR-1 and miR-133a in renal cell carcinoma

European Journal of Cancer, 2012
Hideki Enokida, Nijiro Nohata, Naohiko Seki   +2 more
exaly